Nurix 4
Pharma & Biotech company headquartered in San Francisco, CA. Cross-border supply chain, facility locations, and freight intelligence below.
Nurix Therapeutics NX-0479 CBL-B degrader for solid tumors immune cell activation.
- Industry
- Pharma & Biotech
- Headquarters
- San Francisco, CA
- Revenue
- revenue of $84.0M
- US facilities
- San Francisco, CA
Start a free trial to see Nurix 4’s full freight profile — facility network, cross-border lanes, and shipper intelligence.